Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Asset Utilization Ratio (2020 - 2023)

RAPT Therapeutics' Asset Utilization Ratio history spans 4 years, with the latest figure at 0.0 for Q1 2023.

  • For Q1 2023, Asset Utilization Ratio fell 79.42% year-over-year to 0.0; the TTM value through Mar 2023 reached 0.0, down 79.42%, while the annual FY2022 figure was 0.01, 72.64% down from the prior year.
  • Asset Utilization Ratio for Q1 2023 was 0.0 at RAPT Therapeutics, down from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.05 in Q1 2021 and bottomed at 0.0 in Q1 2023.
  • The 4-year median for Asset Utilization Ratio is 0.02 (2021), against an average of 0.02.
  • The largest annual shift saw Asset Utilization Ratio crashed 45.56% in 2022 before it crashed 79.42% in 2023.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.04 in 2020, then crashed by 54.94% to 0.02 in 2021, then plummeted by 64.97% to 0.01 in 2022, then crashed by 46.36% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for RAPT's Asset Utilization Ratio are 0.0 (Q1 2023), 0.01 (Q4 2022), and 0.01 (Q3 2022).